T. Rowe Price Mid-Cap Growth Fund RPMGX

Medalist Rating as of | See T. Rowe Price Investment Hub
  • NAV / 1-Day Return 99.37  /  +0.68 %
  • Total Assets 21.2B
  • Adj. Expense Ratio
    0.770%
  • Expense Ratio 0.770%
  • Distribution Fee Level Below Average
  • Share Class Type No Load
  • Category Mid-Cap Growth
  • Investment Style Mid Growth
  • Min. Initial Investment 2,500
  • Status Open
  • TTM Yield 0.00
  • Turnover 32%

USD | NAV as of Oct 02, 2026 | 1-Day Return as of Oct 02, 2026, 10:54 PM GMT+0

Morningstar’s Analysis RPMGX

Will RPMGX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

Big shoes, capable feet.

Analyst David Carey

David Carey

Analyst

Summary

The T. Rowe Price Mid-Cap Growth strategy, which includes a Canadian subadvised vehicle and a separately managed account, remains an appealing option despite the retirement of its longtime lead manager.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings RPMGX

  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 19.8
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Agilent Technologies Inc

2.80 622M
Healthcare

Snowflake Inc Ordinary Shares

2.33 516M
Technology

Aggregate Miscellaneous Equity

2.29 509M
—

Mettler-Toledo International Inc

2.11 468M
Healthcare

PTC Inc

1.88 417M
Technology

Keysight Technologies Inc

1.83 405M
Technology

Manhattan Associates Inc

1.71 379M
Technology

Tyler Technologies Inc

1.69 374M
Technology

Veeva Systems Inc Class A

1.60 356M
Healthcare

Yum Brands Inc

1.56 346M
Consumer Cyclical

Sponsor Center